Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $135 at RBC Capital

February 4, 2021 7:00 AM
RBC Capital analyst Randall Stanicky raised the price target on Abbvie (NYSE: ABBV) to $135.00 (from $129.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles